Future Care for Medical Industries (FCMI) results, Q4 2024
Net profit, assets, equity and cash flow for Q4 2024, against the same period a year earlier, from the published financial statements.
Net profit6.6 millionEGP · +430.8% vs the same period a year earlier
Total assets112 millionEGP · +7.8% vs the same period a year earlier
Shareholders' equity45.79 millionEGP · −25.0% vs the same period a year earlier
Operating cash flow9.46 millionEGP · −59.0% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q4 2024 was about 6.6 million EGP, up +430.8% from 1.24 million EGP in Q4 2023.
- Total assets at the end of Q4 2024 were about 112 million EGP, and shareholders' equity about 45.79 million EGP.
- Operating cash flow for Q4 2024 was positive at 9.46 million EGP.
Key lines against the same period a year earlier
This periodQ4 2023Change
Net profit6.6 million1.24 million+430.8%
Gross profit13.69 million8.39 million+63.1%
Total assets112 million104 million+7.8%
Total liabilities66.31 million42.94 million+54.4%
Shareholders' equity45.79 million61.07 million−25.0%
Total liabilities and equity112 million104 million+7.8%
Operating cash flow9.46 million23.05 million−59.0%
Investing cash flow-134 thousand-2.77 million+95.1%
Financing cash flow-739 thousand-19.49 million+96.2%
Net change in cash8.58 million785 thousand+992.7%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy